Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Metal-organic framework-derived bamboo-like nitrogen-doped graphene tubes as an active matrix for hybrid oxygen-reduction electrocatalysts.

Small 2015 March 26
In this work, large size (i.e., diameter > 100 nm) graphene tubes with nitrogen-doping are prepared through a high-temperature graphitization process of dicyandiamide (DCDA) and Iron(II) acetate templated by a novel metal-organic framework (MIL-100(Fe)). The nitrogen-doped graphene tube (N-GT)-rich iron-nitrogen-carbon (Fe-N-C) catalysts exhibit inherently high activity towards the oxygen reduction reaction (ORR) in more challenging acidic media. Furthermore, aiming to improve the activity and stability of conventional Pt catalysts, the ORR active N-GT is used as a matrix to disperse Pt nanoparticles in order to build a unique hybrid Pt cathode catalyst. This is the first demonstration of the integration of a highly active Fe-N-C catalyst with Pt nanoparticles. The synthesized 20% Pt/N-GT composite catalysts demonstrate significantly enhanced ORR activity and H(2) -air fuel cell performance relative to those of 20% Pt/C, which is mainly attributed to the intrinsically active N-GT matrix along with possible synergistic effects between the non-precious metal active sites and the Pt nanoparticles. Unlike traditional Pt/C, the hybrid catalysts exhibit excellent stability during the accelerated durability testing, likely due to the unique highly graphitized graphene tube morphologies, capable of providing strong interaction with Pt nanoparticles and then preventing their agglomeration.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app